Atlas Venture Life Science Advisors, LLC Long-Term Concentrated

CIK: 0001917529 · Show all filings

Period: Q3 2022 (← Previous) (Next →)

Filing Date: Nov 9, 2022

Total Value ($000): $906,163 (100.0% shares, 0.0% debt)

Holdings (17)

— Third Harmonic Bio, Inc. 22.8%

Value ($000) $206,922 Shares 10,907,859 Est. Cost $18.97 Unrealized —

DAWN Day One Biopharmaceuticals, Inc. 18.1%

Value ($000) $163,628 Shares 8,169,171 Est. Cost $19.68 Unrealized +8.1%

KYMR Kymera Therapeutics, Inc. 16.5%

Value ($000) $149,684 Shares 6,875,698 Est. Cost $58.25 Unrealized -54.7%

DYN Dyne Therapeutics, Inc. 12.5%

Value ($000) $113,473 Shares 8,934,902 Est. Cost $14.05 Unrealized -18.4%

REPL Replimune Group, Inc. 5.9%

Value ($000) $53,680 Shares 3,108,300 Est. Cost $29.91 Unrealized -36.2%

— Vigil Neuroscience, Inc. 5.9%

Value ($000) $53,116 Shares 5,836,874 Est. Cost $7.03 Unrealized —

— Generation Bio, Co. 4.9%

Value ($000) $43,961 Shares 8,278,876 Est. Cost $7.08 Unrealized —

— Aerovate Therapeutics, Inc. 4.3%

Value ($000) $38,597 Shares 2,327,909 Est. Cost $11.79 Unrealized —

— Akero Therapeutics, Inc. 3.7%

Value ($000) $33,854 Shares 994,251 Est. Cost $21.15 Unrealized —

— Ikena Oncology, Inc. 2.0%

Value ($000) $17,815 Shares 5,018,178 Est. Cost $12.54 Unrealized —

— Gemini Therapeutics, Inc. 1.0%

Value ($000) $8,617 Shares 5,254,365 Est. Cost $2.91 Unrealized —

XLO Xilio Therapeutics, Inc. 0.9%

Value ($000) $8,030 Shares 2,759,344 Est. Cost $17.03 Unrealized -83.7%

— Magenta Therapeutics, Inc. 0.5%

Value ($000) $4,902 Shares 3,476,536 Est. Cost $4.43 Unrealized —

— F-star Therapeutics, Inc. 0.3%

Value ($000) $3,070 Shares 599,524 Est. Cost $5.02 Unrealized —

— AvroBio, Inc. 0.3%

Value ($000) $2,905 Shares 4,520,863 Est. Cost $3.85 Unrealized —

SPRO Spero Therapeutics, Inc. 0.2%

Value ($000) $2,062 Shares 1,031,160 Est. Cost $15.88 Unrealized -93.7%

VRDN Viridian Therapeutics, Inc. 0.2%

Value ($000) $1,847 Shares 90,072 Est. Cost $18.63 Unrealized -3.5%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Third Harmonic Bio, Inc.	10,907,859	$206,922	22.8%	$18.97	—	Common Stock	88427A107
DAWN	Day One Biopharmaceuticals, Inc.	8,169,171	$163,628	18.1%	$19.68	+8.1%	Common Stock	23954D109
KYMR	Kymera Therapeutics, Inc.	6,875,698	$149,684	16.5%	$58.25	-54.7%	Common Stock	501575104
DYN	Dyne Therapeutics, Inc.	8,934,902	$113,473	12.5%	$14.05	-18.4%	Common Stock	26818M108
REPL	Replimune Group, Inc.	3,108,300	$53,680	5.9%	$29.91	-36.2%	Common Stock	76029N106
—	Vigil Neuroscience, Inc.	5,836,874	$53,116	5.9%	$7.03	—	Common Stock	92673K108
—	Generation Bio, Co.	8,278,876	$43,961	4.9%	$7.08	—	Common Stock	37148K100
—	Aerovate Therapeutics, Inc.	2,327,909	$38,597	4.3%	$11.79	—	Common Stock	008064107
—	Akero Therapeutics, Inc.	994,251	$33,854	3.7%	$21.15	—	Common Stock	00973Y108
—	Ikena Oncology, Inc.	5,018,178	$17,815	2.0%	$12.54	—	Common Stock	45175G108
—	Gemini Therapeutics, Inc.	5,254,365	$8,617	1.0%	$2.91	—	Common Stock	36870G105
XLO	Xilio Therapeutics, Inc.	2,759,344	$8,030	0.9%	$17.03	-83.7%	Common Stock	98422T100
—	Magenta Therapeutics, Inc.	3,476,536	$4,902	0.5%	$4.43	—	Common Stock	55910K108
—	F-star Therapeutics, Inc.	599,524	$3,070	0.3%	$5.02	—	Common Stock	30315R107
—	AvroBio, Inc.	4,520,863	$2,905	0.3%	$3.85	—	Common Stock	05455M100
SPRO	Spero Therapeutics, Inc.	1,031,160	$2,062	0.2%	$15.88	-93.7%	Common Stock	84833T103
VRDN	Viridian Therapeutics, Inc.	90,072	$1,847	0.2%	$18.63	-3.5%	Common Stock	92790C104